Related Experiment Videos
Tics and vocalizations in children treated with carbamazepine
Pediatrics
|June 1, 1984
Summary
Carbamazepine, used for seizure control, may trigger Tourette's syndrome or worsen tics in susceptible individuals. Symptoms persisted even after discontinuing the medication, suggesting a potential link.
Area of Science:
- Neurology
- Pharmacology
Background:
- Carbamazepine is a widely used antiepileptic drug for seizure management.
- Tourette's syndrome is a neurological disorder characterized by repetitive, involuntary movements and vocalizations (tics).
Observation:
- Three patients developed Tourette's syndrome or experienced exacerbated tics and vocalizations after starting carbamazepine.
- Carbamazepine blood levels were therapeutic, and no signs of intoxication were observed.
- Tics and vocalizations persisted even after carbamazepine discontinuation.
Findings:
- Carbamazepine initiation was associated with the onset or worsening of Tourette's syndrome symptoms in the reported cases.
- The drug's effect on tics appears independent of intoxication levels.
- Persistent symptoms post-discontinuation suggest a potential long-term or triggering effect.
Implications:
- Carbamazepine may act as a trigger for Tourette's syndrome in genetically or otherwise susceptible individuals.
- Clinicians should consider this potential adverse effect when prescribing carbamazepine, especially in patients with a history of tics.
- Further research is warranted to elucidate the mechanism by which carbamazepine might influence tic disorders.